Puri Michal Nath 4

4 · NovoCure Ltd · Filed Mar 5, 2026

Form 4

Period: 2026-03-03

Chief Human Resources Officer

Transactions

Award
Ordinary Shares
[F1]
2026-03-03+40,100→ 202,422 total
Sale
Ordinary Shares
[F2][F3]
2026-03-04$13.31/sh−1,100$14,636→ 201,322 total
Award
Stock Option (Right to Buy)
[F4]
2026-03-03+58,672→ 58,672 total
Exercise: $13.30Exp: 2036-03-03→ Ordinary Shares (58,672 underlying)

Footnotes (4)

[F1]Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.
[F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
[F3]This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.
[F4]Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

Signature

Steven Robbins, as attorney in fact for Puri, Michal Nath|2026-03-05

Documents

1 file